Latest Cervarix Stories
The Global Alliance for Vaccines and Immunization announced on Thursday an initiative to purchase cervical cancer vaccines for up to 2 million women and girls in nine developing nations by 2015.
The HPV (human papillomavirus) vaccine sufficiently protects against the more serious immediate precursor to invasive cervical cancer (ICC), particularly when given to young adolescent girls before they become sexually active.
A government medical panel said on Tuesday that the controversial HPV shot given to girls should also be given to boys to help prevent the spread of the sexually transmitted virus.
Pediatricians in Appalachia are less likely than doctors in other areas to encourage parents to have their children receive the human papillomavirus (HPV) vaccine.
New government research shows that two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose treatment.
The research will be presented today [Thursday 7 July] at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol.
An Australian study is the first to show reduction of high-grade cervical abnormalities (HGAs- the precursors to cervical cancer) in women, following the introduction of human papillomavirus (HPV) vaccination programs.
Results of a Chinese study showed that the HPV vaccine did not have significant effects on the number of disease flares or antibody measures in patients with inactive SLE receiving stable doses of medications after administration, and therefore was determined safe to use to prevent HPV in this group of patients.
- A hairdresser.